Home › Pancreatic Cancer › New Jersey
Pancreatic Cancer clinical trials in New Jersey
27 studies for Pancreatic Cancer are looking for participants at sites in New Jersey.
Cities in New Jersey
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Regional Cancer Care, Belleville
- Astera Cancer Care, East Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07562152Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Astera Cancer Care, East Brunswick
- Rutgers Cancer University, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621718A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Astera, LLC, East Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413Pancreatic Cancer Detection Consortium
- Atlantic Health System, Morristown
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06388967A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Atlantic Health System / Morristown Medical Center, Morristown
- Jack & Sheryl Morris Cancer Center, New Brunswick
- Rutgers Cancer Institute, New Brunswick
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US077, Hackensack
- Investigative Site US017, Morristown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07522073A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Memorial Sloan Kettering - Hackensack - Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Cancer Center - Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Atlantic Health System, Morristown
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Englewood Hospital and Medical Center, Englewood
- CentraState Medical Center, Freehold
- Morristown Medical Center, Morristown
- and 2 more
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- START New Jersey, East Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07644559Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05837767Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- Cooperman Barnabas Medical Center, Livingston
- Monmouth Medical Center, Long Branch
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT04172532Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooper Hospital University Medical Center, Camden
- Jefferson Cherry Hill Hospital, Cherry Hill
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT03334708Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
- Cooper Hospital University Medical Center, Camden
- Cooper Hospital University Medical Center, Voorhees Township
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06593431Pancreatic Cancer Early Detection Consortium
- Hackensack Meridian Health, Hackensack
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Jul 22, 2026 · NCT04970056A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07612046A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT07671339A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
- Atlantic Health, Summit
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT07049055Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Astera, East Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255A Study of Multiparametric Ultrasound Imaging Methods
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Dec 12, 2025 · NCT07270237VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #9, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 5, 2025 · NCT05932862American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
- Atlantic Health, Millburn
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT02674100From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.